Qube Research & Technologies LTD Pacira Bio Sciences, Inc. Transaction History

Qube Research & Technologies LTD

$72.9 Billion
Q4 2024

A detailed history of Qube Research & Technologies LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 84,039 shares of PCRX stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,039

Previous 360,205 76.67%

Holding current value

$2.14 Million

Previous $5.42 Million 70.81%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $4.23 Million - $5.61 Million	-276,166 Reduced 76.67%	84,039 $1.58 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $2.7 Million - $6.57 Million	231,014 Added 178.82%	360,205 $5.42 Million
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $3.29 Million - $4.07 Million	129,191 New	129,191 $3.7 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $546,318 - $713,882	17,807 New	17,807 $546,000
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $557,607 - $680,805	-15,694 Reduced 29.78%	37,010 $1.51 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $2.01 Million - $3.03 Million	52,704 New	52,704 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $1.22 Million - $1.94 Million	23,754 New	23,754 $1.39 Million
Q1 2022 May 09, 2022	SELL	$60.03 - $76.49 $468,113 - $596,469	-7,798 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$47.97 - $62.21 $36,840 - $47,777	-768 Reduced 8.97%	7,798 $469,000
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $1,748 - $1,961	-32 Reduced 0.37%	8,566 $480,000
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $227,961 - $269,601	3,852 Added 81.16%	8,598 $522,000
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $281,485 - $374,079	4,746 New	4,746 $333,000
Q3 2020 Nov 12, 2020	SELL	$51.97 - $63.0 $744,678 - $902,727	-14,329 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $441,333 - $751,842	14,329 New	14,329 $752,000
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $380,616 - $679,481	-13,402 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $486,626 - $627,615	13,402 New	13,402 $607,000

Others Institutions Holding PCRX

# of Institutions

253

Shares Held

48.8M

Call Options Held

554K

Put Options Held

136K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.17B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Pacira Bio Sciences, Inc. Transaction History